Clinical Trial: A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738991) titled 'A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers' on July 16.

Brief Summary: A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-PEG, and US-Neulasta(R), and to Evaluate Safety in Healthy Adult Male Volunteers

Study Start Date: July 03

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: BIOLOGICAL: NKF-PEG

NKF-PEG administered as a single 6 mg SC dose in the periumbilical area

BIOLOGICAL: US-Neulasta

US-Neulasta adm...